Related Experiment Video
Updated: Jan 10, 2026

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
Published on: January 27, 2019
Role of vitamin C infusion in postoperative mechanically ventilated neonates with sepsis: a randomized controlled
Asmaa Mahmoud Elmesiry1, Mai Rabie Elsheikh2, Khalid Mohamed Elshimy3
1Pediatrics and Neonatology Department, Faculty of Medicine, Tanta University, Alestad Street, Tanta, 31527, Al Gharbia, Egypt. asmaa.elmesery@med.tanta.edu.eg.
Abstract:
This research investigated the efficacy of intravenous vitamin C administration in septic, mechanically ventilated (MV) full-term neonates following surgical interventions. This double-blinded randomized controlled trial included 50 full-term neonates who required mechanical ventilation and developed confirmed sepsis after surgery. Neonates were randomly assigned to receive either standard sepsis management with placebo (No Vitamin C group) or standard protocol with vitamin C infusion, administered as a 0.5 g/kg loading dose followed by a maintenance dose of 0.5 g/kg/h over 6 h, continued for 7 to 10 days (Vitamin C group). Respiratory rate and peak inspiratory pressure were significantly lower at 24 h, 72 h, and 120 h in the Vitamin C group than in the No Vitamin C group. FiO₂ requirements were significantly reduced at 72 h and 120 h in the Vitamin C group. SpO2/FiO2 did not change across groups at baseline and 24 h but were considerably higher in the Vitamin C group at 72 h and 120 h. Duration of MV (4.44 ± 1.23 vs. 5.64 ± 2.2 days, p = 0.021) and inotropic support needs (40% vs. 76%, p = 0.010) were significantly lower in the Vitamin C group. There were no statistically significant differences in mortality rates or the duration of hospitalization, including stays at neonatal intensive care units (NICU) or the hospital.
Conclusion:
Vitamin C infusion significantly improved respiratory parameters and reduced the duration of MV and inotropic support requirements in septic neonates following surgery, though it did not significantly affect the NICU or hospital length of stay or mortality.
Trial Registration:
registered on ClinicalTrials.gov (ID: NCT06780345) (date: 17/1/2025).
What Is Known:
• In neonatal intensive care units (NICU), neonatal sepsis continues to be a major cause of death and morbidity. • Vitamin C has become a possible therapeutic intervention given its many pathways in sepsis control.
What Is New:
• Vitamin C infusion significantly improved respiratory parameters and reduced the duration of MV and inotropic support requirements in septic neonates following surgery, though it did not significantly affect the NICU or hospital length of stay or mortality.
Related Concept Videos
Acute Respiratory Failure-IV
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Acute Respiratory Failure-III
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...

